Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study of a New Screening Program for Major Aneuploidies (T21, T18, T13) in the Emilia-Romagna Region (SAPERER)

NCT04437992 is registered in ClinicalTrials.gov with Azienda Usl di Bologna as lead sponsor.

NCT NCT04437992
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04437992 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study of a New Screening Program for Major Aneuploidies (T21, T18, T13) in the Emilia-Romagna Region (SAPERER)
Lead sponsor
Azienda Usl di Bologna
Phase
Observational
Overall status
Unknown status
Start date
January 27, 2020
Completion date
April 27, 2021
Enrollment
7,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autosomal aneuploidy